TABLE 4.
Biological activity parameter of the selected bioactive compounds.
| S/L No. | Compound name | Biological activity prediction | |
|---|---|---|---|
| Protease inhibitor | Enzyme inhibitor | ||
| 1. | Vitamin E acetate | 0.22 | 0.16 |
| 2. | Methyl gamma-linolenate | 0.03 | 0.23 |
| 3. | Clionasterol | 0.07 | 0.51 |
| 4. | Juniper camphor | −0.70 | 0.29 |
| 5. | Ethyl 4-fluoro-1-methyl-1H-imidazole-5-carboxylate | −0.98 | −0.12 |
| 6. | Bicyclo[3.3.1]nonane-2,4-dione, 9,9-dimethoxy- | −0.67 | −0.12 |
| 7. | alpha.-Amyrin | 0.19 | 0.60 |
| 8. | Moretenone | 0.00 | 0.37 |
| 9. | 6-Methoxy-2,5,8-trimethyl 2-(4,8,12trimethyltridecyl) 3,4-dihydrochromene | 0.19 | 0.13 |
| 10. | Betulinaldehyde | 0.20 | 0.53 |
| 11. | Bicyclo[4.3.0]nonane, 1 isopropenyl-4,5-dimethyl-5-phenylsulfonylmethyl | 0.30 | 0.27 |
| 12. | Tert-Butyl(5-isopropyl-2-methylphenoxy)dimethylsilane | 0.53 | 1.03 |
| 13. | Behenyl behenate | 0.45 | −0.06 |
| 14. | Ergost-5-en-3-ol, (3.beta.,24R)- | 0.01 | 0.50 |
| 15. | Erucic acid | 0.18 | 0.23 |
| 16. | Glyceryl palmitate | 0.13 | 0.24 |
| 17. | Methyl heneicosanoate | 0.06 | 0.04 |
| 18. | Methyl palmitate | −0.13 | 0.04 |
| 19. | Ethyl linoleate | 0.03 | 0.18 |
| 20. | 1,3-Dihydroxypropan-2-yl (9E,12E,15E)-octadeca 9,12,15-trienoate | 0.20 | 0.43 |
| 21. | Palmitic acid | −0.04 | 0.18 |
| 22. | Stearic acid | 0.06 | 0.20 |
| 23. | Glyceryl monostearate | 0.15 | 0.22 |
| 24. | Olean-12-en-3-ol, acetate, (3.beta.)- | 0.06 | 0.48 |
| 25. | Methyl pentadecanoate | −0.20 | 0.01 |
| 26. | Phytol | 0.00 | 0.31 |
| 27. | Tridecanedial | −0.17 | 0.11 |
| 28. | Trilinolein | −2.33 | −3.17 |
| 29. | Methyl n-undecanoate | −0.56 | −0.17 |
| 30. | Vitamin E | 0.28 | 0.24 |
| Standard drugs | |||
| 31. | Nelfinavir | 0.58 | −0.02 |
| 32. | Lopinavir | 0.42 | −0.37 |